Verona Pharma plc
Total Trades
94
Buys
6
Sells
72
Largest Trade
N/A
Insiders
13
Institutional Funds
1
Inst. Value
$100K–$500K
Activist Filings
34
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Fisher Andrew | General Counsel | SELL | $500K+ | 80K | $11.53 | Jun 18, 2025 |
| Fisher Andrew | General Counsel | EXERCISE | $100K–$500K | 80K | $2.01 | Jun 18, 2025 |
| Hahn Mark W | CFO | SELL | $1M+ | 400K | $11.40 | Jun 13, 2025 |
| ZACCARDELLI DAVID | President and CEO | SELL | $1M+ | 400K | $11.40 | Jun 13, 2025 |
| Hahn Mark W | CFO | SELL | $1M+ | 400K | $9.33 | May 29, 2025 |
| ZACCARDELLI DAVID | President and CEO | SELL | $1M+ | 400K | $9.34 | May 29, 2025 |
| Sinha Vikas | Director | EXERCISE | $50K–$100K | 160K | $0.50 | May 22, 2025 |
| Sinha Vikas | Director | SELL | $1M+ | 160K | $9.39 | May 22, 2025 |
| Fisher Andrew | General Counsel | SELL | $500K+ | 80K | $8.57 | May 16, 2025 |
| Fisher Andrew | General Counsel | EXERCISE | $100K–$500K | 80K | $2.11 | May 16, 2025 |
| ACKERMANN CHRISTINA | Director | SELL | $100K–$500K | 40K | $8.44 | May 16, 2025 |
| ACKERMANN CHRISTINA | Director | EXERCISE | $50K–$100K | 40K | $1.93 | May 16, 2025 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $1M+ | 115K | $8.82 | May 8, 2025 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $100K–$500K | 49K | $8.95 | May 5, 2025 |
| Rickard Kathleen A. | Chief Medical Offi… | EXERCISE | N/A | 50K | — | May 5, 2025 |
| Hahn Mark W | CFO | EXERCISE | N/A | 200K | — | May 5, 2025 |
| Hahn Mark W | CFO | SELL | $1M+ | 587K | $9.05 | May 5, 2025 |
| ZACCARDELLI DAVID | President and CEO | EXERCISE | N/A | 200K | — | May 5, 2025 |
| ZACCARDELLI DAVID | President and CEO | SELL | $1M+ | 587K | $9.05 | May 5, 2025 |
| Fisher Andrew | General Counsel | SELL | $100K–$500K | 26K | $8.98 | May 2, 2025 |
| Fisher Andrew | General Counsel | EXERCISE | N/A | 86K | — | May 2, 2025 |
| ZACCARDELLI DAVID | President and CEO | EXERCISE | N/A | 230K | — | May 2, 2025 |
| ZACCARDELLI DAVID | President and CEO | SELL | $500K+ | 90K | $8.98 | May 2, 2025 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $100K–$500K | 34K | $8.98 | May 2, 2025 |
| Rickard Kathleen A. | Chief Medical Offi… | EXERCISE | N/A | 86K | — | May 2, 2025 |
| Hahn Mark W | CFO | SELL | $500K+ | 90K | $8.98 | May 2, 2025 |
| Hahn Mark W | CFO | EXERCISE | N/A | 230K | — | May 2, 2025 |
| Sinha Vikas | Director | EXERCISE | $15K–$50K | 20K | $1.40 | May 2, 2025 |
| Sinha Vikas | Director | SELL | $100K–$500K | 20K | $8.92 | May 2, 2025 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $500K+ | 79K | $8.35 | Mar 14, 2025 |
| Hahn Mark W | CFO | SELL | $500K+ | 113K | $5.01 | Dec 3, 2024 |
| ZACCARDELLI DAVID | President and CEO | SELL | $500K+ | 125K | $5.00 | Dec 3, 2024 |
| Hahn Mark W | CFO | SELL | $1K–$15K | 2K | $5.00 | Nov 26, 2024 |
| ZACCARDELLI DAVID | President and CEO | SELL | $1K–$15K | 2K | $5.00 | Nov 26, 2024 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $1M+ | 240K | $4.90 | Nov 26, 2024 |
| EBSWORTH DAVID R | Director | BUY | $50K–$100K | 20K | $4.44 | Nov 18, 2024 |
| ZACCARDELLI DAVID | President and CEO | SELL | $1K–$15K | 2K | $5.00 | Nov 13, 2024 |
| Hahn Mark W | CFO | SELL | $1K–$15K | 2K | $5.00 | Nov 13, 2024 |
| EBSWORTH DAVID R | Director | BUY | $100K–$500K | 39K | $4.80 | Nov 7, 2024 |
| ACKERMANN CHRISTINA | Director | BUY | $100K–$500K | 42K | $4.74 | Nov 7, 2024 |
| ZACCARDELLI DAVID | President and CEO | SELL | $500K+ | 141K | $4.39 | Nov 5, 2024 |
| Hahn Mark W | CFO | SELL | $500K+ | 130K | $4.38 | Nov 5, 2024 |
| Hahn Mark W | CFO | SELL | $500K+ | 145K | $4.38 | Oct 25, 2024 |
| ZACCARDELLI DAVID | President and CEO | SELL | $500K+ | 145K | $4.38 | Oct 25, 2024 |
| ZACCARDELLI DAVID | President and CEO | SELL | $1M+ | 514K | $4.38 | Oct 23, 2024 |
| Hahn Mark W | CFO | SELL | $1M+ | 526K | $4.38 | Oct 23, 2024 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $50K–$100K | 36K | $1.96 | May 3, 2024 |
| Rickard Kathleen A. | Chief Medical Offi… | SELL | $50K–$100K | 36K | $2.22 | Feb 5, 2024 |
| Edwards Martin | Director | BUY | $50K–$100K | 34K | $1.84 | Nov 22, 2023 |
| EBSWORTH DAVID R | Director | BUY | $100K–$500K | 160K | $1.98 | Nov 8, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 20K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Pentwater Capital Management LP
SC 13G · Nov 14, 2025
0.0%
0 shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
SC 13G/A · Nov 14, 2025
1.2%
1.0M shares
SC 13G/A · Aug 14, 2025
0.7%
594K shares
SC 13G/A · Aug 14, 2025
6.4%
5.5M shares
SC 13G/A · Aug 14, 2025
7.2%
6.1M shares
SC 13G/A · May 15, 2025
7.1%
6.0M shares
SC 13G · May 14, 2025
6.5%
5.5M shares
SC 13G/A · Feb 14, 2025
8.9%
7.8M shares
SC 13G/A · Feb 14, 2025
3.8%
25.0M shares
Growth Equity Opportunities 17, LLC
SC 13D/A · Jan 22, 2025
5.0%
32.7M shares
SC 13G/A · Nov 14, 2024
10.0%
8.5M shares
SC 13G/A · Nov 14, 2024
8.1%
6.6M shares
SC 13G · Nov 14, 2024
5.2%
33.7M shares
SC 13G/A · Nov 14, 2024
3.9%
25.4M shares
SC 13G/A · Nov 14, 2024
3.1%
20.3M shares
Growth Equity Opportunities 17, LLC
SC 13D/A · Aug 29, 2024
6.9%
44.7M shares
SC 13G · Jul 30, 2024
6.3%
5.1M shares
SC 13G · Jul 12, 2024
5.1%
32.9M shares
SC 13G/A · Feb 14, 2024
10.0%
7.5M shares
SC 13G/A · Feb 14, 2024
4.8%
3.9M shares
SC 13D/A · May 16, 2023
4.8%
3.8M shares
SC 13G/A · Apr 25, 2023
0.0%
0 shares
SC 13G · Apr 20, 2023
5.6%
4.5M shares
SC 13G/A · Feb 14, 2023
10.0%
7.7M shares
SC 13G/A · Feb 13, 2023
3.8%
23.1M shares
SC 13G/A · Feb 9, 2023
5.5%
32.9M shares
SC 13D/A · Dec 27, 2022
5.6%
4.3M shares
Growth Equity Opportunities 17, LLC
SC 13D/A · Sep 7, 2022
7.9%
46.4M shares
SC 13D/A · Aug 12, 2022
6.9%
5.0M shares
SC 13D/A · Aug 11, 2022
4.4%
21.3M shares
SC 13G/A · Aug 10, 2022
10.5%
51.1M shares
SC 13G/A · Feb 14, 2022
10.0%
48.8M shares
SC 13G/A · Feb 11, 2022
0.0%
0 shares